Yes, catheter ablation can absolutely be performed while a patient is in atrial fibrillation.
Catheter ablation does not require the patient to be in sinus rhythm at the time of the procedure—in fact, many ablations are performed while patients are actively in AF, particularly for persistent AF where the arrhythmia is ongoing by definition. 1
Clinical Context and Reasoning
The presence of AF during the procedure does not contraindicate ablation. Here's the algorithmic approach:
For Paroxysmal AF:
- Patients may be in sinus rhythm or AF at the time of procedure
- If in sinus rhythm, the electrophysiologist can still map and ablate based on anatomical landmarks and voltage mapping
- If in AF, real-time mapping of the arrhythmia can actually help identify triggers and drivers
For Persistent AF:
- By definition, these patients are continuously in AF
- The procedure is performed while they are in the arrhythmia
- Pulmonary vein isolation remains the cornerstone technique regardless of rhythm at procedure start 2, 3
Critical Safety Consideration: Anticoagulation
The key issue is NOT whether the patient is in AF during the procedure, but rather ensuring adequate anticoagulation before and during ablation:
- If AF duration >24 hours: provide at least 3 weeks of therapeutic anticoagulation before the procedure 1
- This applies whether planning cardioversion or ablation
- Continue anticoagulation according to CHA₂DS₂-VASc score after the procedure, regardless of whether sinus rhythm is achieved 1
Common Pitfall to Avoid
Do not delay ablation simply because the patient is in AF at the time of scheduling. The rhythm status at procedure time is irrelevant to the technical feasibility. The critical factors are:
- Adequate pre-procedural anticoagulation (≥3 weeks if AF >24 hours)
- Appropriate patient selection (symptomatic AF, failed or intolerant to antiarrhythmics for second-line, or first-line for paroxysmal AF) 1
- Stroke risk assessment independent of rhythm status
The 2024 ESC guidelines explicitly recommend catheter ablation as either first-line therapy for paroxysmal AF or second-line after antiarrhythmic drug failure, with no requirement for the patient to be in sinus rhythm at the time of the procedure 1.